Sign up to save your podcasts
Or
Share Bilal Bham on Life Sciences Strategy, Human Perspective & Building Amodaia | Pharma Prescribed
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Bilal Bham on Life Sciences Strategy, Human Perspective & Building Amodaia | Pharma Prescribed
Bilal Bham — founder and CEO of Amodaia — joins Adam Walker to explore what it really takes to guide a biotech, pharma or medtech company through its most critical decision points.
Bilal brings nearly two decades of life sciences experience across regulatory affairs, medical affairs, market access, marketing communications and fundraising. But what sets him apart is the lens through which he approaches all of it: lived experience. His own journey with Graves' disease and thyroid eye disease, alongside family mental health challenges and his experience as an autistic leader, has shaped a consultancy built around the belief that science and human perspective are inseparable.
This is a conversation about the gap between clinical data and commercial reality — and what it takes to close it.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/6gPpTo25uSfdcVQCtcBw2X
Apple Podcasts → https://podcasts.apple.com/us/podcast/pharma-prescribed-with-bilal-bham-ceo-of-amodaia/id1829715970?i=1000769475494
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://pharmaprescribed.podbean.com/
📖 WHAT WE COVER
- What Amodaia does and why integrated consultancy beats siloed departments
- Navigating regulatory, medical affairs and market access as a unified strategy
- Why patient-first thinking must drive commercial strategy — not follow it
- Bridging the gap between clinical data and the human story payers and providers need to hear
- Fundraising realities for emerging biotechs at critical decision points
- How lived experience with chronic illness and neurodiversity shapes Bilal's leadership
- Why the most important question in drug development is still: does this improve a patient's life?
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Bilal Bham — founder of Amodaia
2:00 The mission: helping biotechs survive & reach patients
3:30 From medical writing to cross-functional consultancy
5:00 "Telling them their baby's ugly" — diagnosing client friction
7:00 The consultation process: NDAs, diagnostics & trust building
9:00 Trust, loyalty, respect — Amodaia's six core values
11:00 Shared experience: redundancy as the spark for independence
12:30 Losing his father, returning home & going freelance
15:00 Growth strategy & the AI reset reshaping life sciences
17:30 Building proprietary AI vs off-the-shelf tools
20:00 Breaking pharma silos — why pillars beat silos
22:00 The AI stack: Claude, ChatGPT, Scite, Perplexity & beyond
24:30 Scaling lean — seven-figure revenue without a big headcount
26:30 It takes a village: mentors inside and outside the industry
30:00 Self-education through audiobooks — dead time to active time
32:30 Empathy as a leadership principle — "it costs nothing to be nice"
33:00 Living with autism, ADHD & the power of neurodiversity
37:30 Masking, diagnosis & finding a methodology that works
40:00 Routine as regulation — bookending the day
42:00 Quick-fire round
44:00 Closing reflections
👤 ABOUT BILAL BHAM
Bilal Bham is the founder and CEO of Amodaia, a senior-led life science consultancy supporting biotech, pharma and medtech teams across regulatory affairs, medical affairs, market access, marketing communications and fundraising. With nearly two decades in life sciences, he brings both strategic rigour and a human perspective shaped by his own experience with Graves' disease, thyroid eye disease and life as an autistic leader.
💼 LinkedIn: Search "Bilal Bham Amodaia"
🎙️ ABOUT PHARMA PRESCRIBED
Pharma Prescribed is the podcast for people who want the conversations the life sciences industry rarely makes time for — hosted by biometrics consultant Adam Walker. New episodes every week covering clinical research, digital health, mental wellbeing and leadership.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#BilalBham #Amodaia #LifeSciences #Biotech #PharmaStrategy #MarketAccess #RegulatoryAffairs #PatientFirst #PharmaPrescribed #AdamWalker #HealthcareLeadership #Neurodiversity
View all episodes
By Adam WalkerBilal Bham — founder and CEO of Amodaia — joins Adam Walker to explore what it really takes to guide a biotech, pharma or medtech company through its most critical decision points.
Bilal brings nearly two decades of life sciences experience across regulatory affairs, medical affairs, market access, marketing communications and fundraising. But what sets him apart is the lens through which he approaches all of it: lived experience. His own journey with Graves' disease and thyroid eye disease, alongside family mental health challenges and his experience as an autistic leader, has shaped a consultancy built around the belief that science and human perspective are inseparable.
This is a conversation about the gap between clinical data and commercial reality — and what it takes to close it.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/6gPpTo25uSfdcVQCtcBw2X
Apple Podcasts → https://podcasts.apple.com/us/podcast/pharma-prescribed-with-bilal-bham-ceo-of-amodaia/id1829715970?i=1000769475494
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://pharmaprescribed.podbean.com/
📖 WHAT WE COVER
- What Amodaia does and why integrated consultancy beats siloed departments
- Navigating regulatory, medical affairs and market access as a unified strategy
- Why patient-first thinking must drive commercial strategy — not follow it
- Bridging the gap between clinical data and the human story payers and providers need to hear
- Fundraising realities for emerging biotechs at critical decision points
- How lived experience with chronic illness and neurodiversity shapes Bilal's leadership
- Why the most important question in drug development is still: does this improve a patient's life?
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Bilal Bham — founder of Amodaia
2:00 The mission: helping biotechs survive & reach patients
3:30 From medical writing to cross-functional consultancy
5:00 "Telling them their baby's ugly" — diagnosing client friction
7:00 The consultation process: NDAs, diagnostics & trust building
9:00 Trust, loyalty, respect — Amodaia's six core values
11:00 Shared experience: redundancy as the spark for independence
12:30 Losing his father, returning home & going freelance
15:00 Growth strategy & the AI reset reshaping life sciences
17:30 Building proprietary AI vs off-the-shelf tools
20:00 Breaking pharma silos — why pillars beat silos
22:00 The AI stack: Claude, ChatGPT, Scite, Perplexity & beyond
24:30 Scaling lean — seven-figure revenue without a big headcount
26:30 It takes a village: mentors inside and outside the industry
30:00 Self-education through audiobooks — dead time to active time
32:30 Empathy as a leadership principle — "it costs nothing to be nice"
33:00 Living with autism, ADHD & the power of neurodiversity
37:30 Masking, diagnosis & finding a methodology that works
40:00 Routine as regulation — bookending the day
42:00 Quick-fire round
44:00 Closing reflections
👤 ABOUT BILAL BHAM
Bilal Bham is the founder and CEO of Amodaia, a senior-led life science consultancy supporting biotech, pharma and medtech teams across regulatory affairs, medical affairs, market access, marketing communications and fundraising. With nearly two decades in life sciences, he brings both strategic rigour and a human perspective shaped by his own experience with Graves' disease, thyroid eye disease and life as an autistic leader.
💼 LinkedIn: Search "Bilal Bham Amodaia"
🎙️ ABOUT PHARMA PRESCRIBED
Pharma Prescribed is the podcast for people who want the conversations the life sciences industry rarely makes time for — hosted by biometrics consultant Adam Walker. New episodes every week covering clinical research, digital health, mental wellbeing and leadership.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#BilalBham #Amodaia #LifeSciences #Biotech #PharmaStrategy #MarketAccess #RegulatoryAffairs #PatientFirst #PharmaPrescribed #AdamWalker #HealthcareLeadership #Neurodiversity